You are here

Article info

Article menu
Download PDFPDF
Prognosis
Cohort
β-blockers associated with reduced all-cause mortality in COPD

Authors

  1. Correspondence to Donald P Tashkin
    David Geffen School of Medicine at UCLA, Department of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA; dtashkin{at}mednet.ucla.edu
View Full Text

Citation

Tashkin DP
β-blockers associated with reduced all-cause mortality in COPD
BMJ Evidence-Based Medicine 2012;17:31-32.

Publication history

  • First published September 26, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions